Sagent Pharmaceuticals Lands $40,000,000 Series B Round

  • Feed Type
  • Date
    4/9/2010
  • Company Name
    Sagent Pharmaceuticals
  • Mailing Address
    1901 N. Roselle Road Schaumburg, IL 60195
  • Company Description
    SAGENT is a forward-thinking specialty injectables company that goes beyond just listening to what our customers have to say. We’re committed to responding to what we hear. With speed, with flexibility, and with efficiency.
  • Website
    http://www.sagentpharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Undisclosed

Trending on Xconomy